Verticals / Pharma, medtech & health distribution / Diagnostics & labs
Diagnostics & labs
12
Companies
with a public disclosure
7
Gave a number
a disclosed NPS
73
Median latest NPS
last 3 years
9
Silent
known companies, nothing published
Lighthouse companies
NeoGenomics, Inc.
Diagnostics & labs · neogenomics.com
77NPS · 2026
20262026
“NeoGenomics reported Net Promoter Scores in the high 70s across both segments as it expands its commercial representative force.”
Latest: tipranks.com
SOPHiA GENETICS
Diagnostics & labs · sophos.com
67NPS · 2026
20262026
NRR 117% · 2026Churn 0.4% · 2026
“Expanding usage of SOPHiA DDM™ with existing customers In 2025, we continued to delight our customers and, in doing so, drive meaningful expansion across accounts. We rec…”
Latest: SEC 6-K report
IDEXX Laboratories
Diagnostics & labs · idexx.com
57NPS · 2026
Retention 95% · 2026
“Service in the United States; + Conducted three international commercial expansions in Australia, Germany and the United Kingdom, while expanding our U.S. field-based res…”
Latest: SEC proxy statement
Fresenius Medical Care AG
Diagnostics & labs · freseniusmedicalcare.com
73NPS · 2026
20262026
“Of care and employee engagement relevant to the Group, which emerged from the most recent materiality analysis in 2023. To determine the target achievement, the values re…”
Latest: SEC 6-K report
Myriad Genetics
Diagnostics & labs · myriad.com
72NPS · 2026
20262026
“Also in 2025, our healthcare provider Net Promoter Score was 72.5, a level typically regarded as excellent, reflecting our continued focus on and investment in the patien…”
Latest: SEC proxy statement
Australian Clinical Labs
Diagnostics & labs · acl.com.au
80NPS · 2026
“Australian Clinical Labs achieved Net Promoter Score above 80 based on 440,007 responses in 2026 Annual Report.”
Latest: kalkinemedia.com
More companies
Number of entries in brackets.
Silent
Companies we know of in diagnostics & labs that have published nothing on NPS or retention.
Fortune 500 #98
Genetic Testing
Diagnostics & Genetic Testing
Genomics & Diagnostics
Medical Testing Lab
Pharmaceuticals & Diagnostics
Medical Diagnostics & Imaging
Diagnostics & Genomics
Laboratory Services
About these figures
Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.
NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.